Class III
Ongoing
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Why: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
- Company
- Eugia US LLC
East Windsor, NJ, United States - Reported
- Jun 10, 2026
- Recall started
- May 18, 2026
- Where sold
- US Nationwide.
- Amount
- 168,300 vials
- Full product description
- Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
- Lots / codes affected
- Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.